# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-091820
Filing Date
2022-08-16
Accepted
2022-08-16 17:06:57
Documents
5
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2222180-2_def14a.htm | DEF 14A | 698481
2 | GRAPHIC | lg_synthetic-4clr.jpg | GRAPHIC | 12418
3 | GRAPHIC | tm2222180d2-px_01page4clr.jpg | GRAPHIC | 508815
4 | GRAPHIC | tm2222180d2-px_02page4clr.jpg | GRAPHIC | 394778
5 | GRAPHIC | tm2222180d2-px_03page4clr.jpg | GRAPHIC | 596538
| Complete submission text file | 0001104659-22-091820.txt |  | 2783125

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12584 | Film No.: 221170993
SIC: 2834 Pharmaceutical Preparations